•
XN
XNCR
Xencor, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
928.34M
Volume
362.81K
52W High
$21.00
52W Low
$6.92
Open
$0.00
Prev Close
$12.64
Day Range
0.00 - 0.00
About Xencor, Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Latest News
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire Inc.•Jan 14
Xencor (XNCR) Q2 Revenue Jumps 82%
The Motley Fool•Aug 6
[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire Inc.•Jul 16
Xencor Surges 10.5%: Is This an Indication of Further Gains?
Benzinga•Sep 12
Peeling Back The Layers: Exploring Xencor Through Analyst Insights
Benzinga•Jun 14
Decoding 6 Analyst Evaluations For Xencor
Benzinga•May 10
Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research•May 6
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 2